FDA — authorised 10 March 2015
- Marketing authorisation holder: UNITED THERAP
- Status: approved
🇺🇸 Ch14.18 in United States
FDA authorised Ch14.18 on 10 March 2015
Marketing authorisation
Ch14.18 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Ch14.18 approved in United States?
Yes. FDA authorised it on 10 March 2015.
Who is the marketing authorisation holder for Ch14.18 in United States?
UNITED THERAP holds the US marketing authorisation.